Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification.

Oberthuer A, Berthold F, Warnat P, Hero B, Kahlert Y, Spitz R, Ernestus K, König R, Haas S, Eils R, Schwab M, Brors B, Westermann F, Fischer M (2006) Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification. J Clin Oncol 24(31), 5070-5078. PubMed

Abstract

To develop a gene expression-based classifier for neuroblastoma patients that reliably predicts courses of the disease.

Beteiligte Abteilungen und Gruppen
HKI-Autoren
Identifier

PMID: 17075126